Inmune Bio Inc (INMB)

EBITDA Growth

85.02%

Quarterly · Period ending:

INMB logo

INMB EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported85.02%
INMB Quarterly EBITDA YoY % (100.46% → 85.02%)
High-resolution chart · PNG

INMB ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Inmune Bio Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
85.0192%
45.0149%
43.5018%
46.415%
17.1261%
11.3911%
-10.0131%
-34,408.5714%
-10,702.2222%
-100%
100%
100%
-215.7307%
100%
100%
-100%
-498,400%
-2,379,878.1609%
-3,566,390.7692%
216.9811%
408.7591%
-77.3438%
-128.3843%
66.3848%
-208.7302%
-99.744%
100.458%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.